Purpose: The diversion of controlled substances, particularly narcotics, remains a significant concern in health care. To address this, the pharmacy department is revising the controlled substances and high-diversion drug management policy for ambulatory care clinics, aiming to improve medication safety and compliance with best practices. A key revision is the creation of a standardized log to prevent diversion, ensure accountability, and enhance patient safety. The ASHP Guidelines on Preventing Diversion emphasize the importance of tracking systems, monitoring, documentation, and staff training to reduce misuse and protect patient care.
Description: A rapidly expanding ambulatory care health system, now encompassing over 250 clinics, is acquiring a diverse range of healthcare facilities, each with unique processes for managing controlled substances. These variations create challenges in achieving a consistent, compliant, and efficient approach to tracking. As the system grows, standardizing procedures across clinics is essential to mitigate risks related to regulatory compliance, patient safety, and operational efficiency.
The lack of a standardized system complicates regulatory compliance, quality control, and risk management as the organization grows. Variations in tracking protocols increase the risk of non-compliance with DEA regulations, leading to potential legal and financial consequences. Inconsistent tracking also hinders inventory management, misuse prevention, and waste identification, affecting patient safety and reputation. To address these issues, the health system must implement a standardized controlled substance tracking framework that aligns with regulations, integrates across clinics, and enables centralized monitoring and compliant management.
The policy update aims to improve communication, reinforce security, and create a safer, more accountable environment for patients and providers. The log will support these goals while the health system works to implement Pyxis systems in all 250+ clinics, enhancing management of high-theft medications. A pilot program was launched in select clinics to ensure the log meets policy and evidence-based standards. The ambulatory care nursing department developed multiple log versions, collaborating with clinic staff to assess functionality and alignment with the policy. Feedback from the pilot refined the log and improved integration into daily workflows.
After the pilot, feedback was reviewed to refine the narcotic log. Research shows that iterative feedback and collaboration are crucial for successful healthcare tool implementation. The final log was submitted to the pharmacy department for inclusion in the revised policy, which will be presented to the policy committee for approval. This evidence-based approach ensures the log aligns with best practices and supports regulatory compliance.
Evaluation/outcome: By employing evidence-based methods, the pilot will help refine the narcotic log and ensure it meets both operational needs and regulatory standards. Ultimately, the goal is to roll out the log across all ambulatory care clinics, improving oversight, reducing risks associated with controlled substance misuse, and enhancing overall patient safety.
Learning outcome: Upon completion, participants will be able to evaluate and refine substance tracking systems, ensuring they align with regulatory standards and best practices, and apply these improvements to enhance safety and reduce diversion in clinical settings.